Who to consider for an expanded empiric mdrtb regimen patients in whom tb treatment is failing i. Treatment correlates of successful outcomes in pulmonary multidrugresistant tuberculosis. Over 400,000 new cases of mdr tb occur each year and, although their rates. These will include such topics as mdrtb casefinding, treatment, drug supply, and monitoring and supervision. The bacteria that cause tuberculosis tb can develop resistance to the antimicrobial drugs used to cure the disease. Transitioning to new mdrtb policy in endtb project countries. Guidelines for the management of multidrugresistant tuberculosis mdr tb in myanmar myanmar, may 20. Sep 26, 2018 the niaid strategic plan for tb research proposes to build on an existing foundation of research and resources to advance five tb research priorities targeted at 1 improving fundamental knowledge, 2 advancing diagnosis, 3 preventing initial infection or progression to active disease, 4 improving treatment for all forms of tb in all populations. The evaluation of effectiveness and safety of novel shorter. Nov 27, 2007 the emergence of multidrugresistant tuberculosis mdr tb and, more recently, extensively drugresistant tb xdr tb is widely considered a serious threat to global tb control. Moreover, interruption of tb treatment is a risk factor for the development of mdr tb, a disease that is not only difficult and expensive to treat but also carries high mortality rate. Thus, this study was designed to assess knowledge, attitude and practices of tb patients on treatment and find out if. Diagram to show how mdr tb develops and becomes resistant to isoniazid and rifampicin.
Rr and mdr tb initiated annually 54% 2014 rr and mdr tb success rate 20% of mdr tb cases are initiated on treatment world health organisation 2016 incidence 19,000 rr and mdr tb treatment 11,192 rr and mdr tb initiated annually 54% 2014 rr and mdr tb success rate 60% of dr tb cases are initiated on treatment xdr 27% success rate of those. This file should be updated regularly at least once. Who treatment outcomes for tb patients excluding patients treated. The prevalence of tuberculosis tb can be traced back to 24003400 bc, and the disease still continues to remain as the global threat affecting approximately 10 million people per year. There is a paucity of evidence that assessed studies on the treatment of mdr tb, which focus on the effectiveness of the directly observed. Citc is a project of the university of california, san francisco, funded by the centers for. Spigelman, mdb following nearly 3 decades of neglect, there is now renewed interest in the development of new drugs for the treatment and prevention of tuberculosis i. The number of patients commencing mdr tb treatment increased overall between 2009 and 2012. It is intended to provide practical guidance on an effective alternative method of treatment delivery. Early outcomes in mdrtb and xdrtb patients treated with.
Ethiopia is among the 30 high tb, hiv and mdr tb burden countries, with annual estimated tb incidence of 177100,000 populations and death rate of 25 per 100,000 populations for 2016. National action plan for combating multdrugresistant. Annex 4 list of complementary documents available on the. National mdr xdr tb situation analysis consists of three sections country snapshot, tb case detection and treatment outcome data, and drug resistance data and includes a series of tables. It is not intended to provide complete information on mdr tb, anti tb medications, or medication side effects. Mdrtb planning toolkit introduction and users guide 6 the sections of your plan should correspond to the sections of your national tb strategy. Knowledge, attitude and practicekap of tuberculosis. Guidelines for the programmatic management of drugresistant. Shown are the estimated numbers of cases of multidrugresistant disease including extensively drugresistant disease among cases of pulmonary tuberculosis that were officially reported in 2011. Mdr tb always occurs as a result of human error, for example when someone does not take their full course of treatment.
Pdf cdc pdf 37k multidrugresistant tuberculosis mdr tb what is tuberculosis tb. This is especially true for programs with poor treatment outcomes despite strong program management and patient support. Management of contacts of mdr tb and xdr tb patients. The mdr xdr tb assessment and monitoring tool consists of two main parts divided into sections. Patient data should be recorded on standard ntp treatment cards and documents. But despite the dire need for improved treatment for mdr tb, there has been surprisingly little uptake of. A survival guide for clinicians, third edition was.
Professor bengal college of pharmaceutical sciences and research 2. Currently, the number patients enrolled on treatment is only 25 percent of the estimated 12,000 mdr tb cases. Second line regimens often present the patients best hope for cure, and inappropriate management of a drugresistant case can have lifethreatening consequences. Collaborative group for the metaanalysis of individual patient data in mdrtb treatment2017, ahmad n, ahuja sd, et al. Treatment outcomes for multidrugresistant tuberculosis under. Usaid programs are working with the government and partners to increase scaleup of mdr tb diagnosis and treatment services. Percentage of estimated mdrtb cases enrolled on treatment in 2011. Chapter 9 treatment of drugresistant tuberculosis in special conditions and. Monitoring of tb treatment by smear microscopy for new pulmonary tb patients 50 table 4.
Quick reference for 3mdg mdr tb indicators mdr tb treatment for all patients diagnosed with mdr tb under who endorsed treatment protocols output mdr tb treatment number of mdr tb cases notified to the national tb program output mdr tb treatment number of cases of bacteriologically confirmed dr tb rr andor mdr who began second line treatment. She was thus recused from participating in the 9 november 2015 meeting session on patients, intervention, comparator and outcomes pico question 1 on mdr tb regimen composition for adults and children. But the bad news mdrtb numbers initiated on treatment doubled between 2010 and 20 5,3 to 10,719 mdrtb treatment success rate of 49 %. Tb usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. It was prepared by path for the tuberculosis support contract ii tasc2 tb task order 02 project, ghsi02030003400. These guidelines will replace all previous and current who guidelines on treatment of mdr rr tb. It sets out a nursing approach to planning and delivering patient care, aimed at improving access and quality of care throughout the treatment period. Stop t treatmentadd the following tests if the patient meets the criteria. Public health guidance by presenting the most recent scientific evidence and expert opinions on the topic, this document provides. Agency for international development usaid under the terms of cooperative agreement aidoaaa1400046.
Treatment of drugresistant extrapulmonary tb is complicated by several issues. Drugresistant tuberculosis curry international tuberculosis center. Improvement of mdr tb diagnosis and treatment is a key objective of. Register as treatment failure onduct lpa and dst for. Guidelines for the management of multidrugresistant. There were successive annual increments in new enrolments between 2010 and 2012 in at least 18 countries, and an increase of 50% in 2012 was seen in 15 countries, in comparison with 2011 table 2 and fig.
Stop treatment when 6 months treatment completed discharge as cured educate patient about t prevention and healthy lifestyle positive. Hope emerged when two new drugs, bedaquiline and delamanid, were approved for use in mdr tb patients in 2012 and 20 respectively. Table adapted from the american thoracic society treatment guidelines. Jan 17, 2017 antituberculosis drug resistance is a major public health problem that threatens the progress made in tuberculosis care and control worldwide. Global numbers of cases of multidrugresistant tuberculosis. Treatment of drugresistant tuberculosis american journal of respiratory and critical care medicine, 2019 full guidelines external icon. Updated anti tb medications for the treatment of rr tb and mdr tb. Treatment of tuberculosis tb caused by drugresistant organisms should be done by, or in close consultation with, an expert in the management of these difficult cases.
Who treatment guidelines for drug resistant tuberculosis. The evidence for preventive therapy in mdr tb and xdr tb is very scarce. This publication is made possible by the generous support of the american people through the u. Management of contacts of mdr tb and xdr tb patients ecdc. Treatment of drugresistant tuberculosis american journal of respiratory and critical care medicine, 2019. Ethiopia has notified 125,836 new tb cases and enrolled 702 drugresistant tb case in 2016. In addition, 83% 65 out of 78 of the patients were culturepositive at referral, 56% 44 out of 78 had xdr tb and 33% 26 out of 78 had prexdr tb i. A survival guide for clinicians, third edition was created through a collaboration of the curry international tuberculosis center citc and the state of california department of public health, tuberculosis control branch cdph. Tuberculosis tb is a disease caused by bacteria that are spread from person to person through the air. Modeling the costeffectiveness of multidrug resistant. This rapid communication aims to inform tb programme managers and other stakeholders of who member states about the key implications for mdr tb treatment regimens arising from the new evidence assessment.
In this toolkit, worksheets 3 through 7 use the components of the stop tb. Diagnosis of multidrugresistant tuberculosis and extensively. Treatment success rates of multidrugresistant tuberculosis mdr tb is a key issue that cannot be ignored. Multidrugresistant tuberculosis mdr tb is a form of tuberculosis tb infection caused by bacteria that are resistant to treatment with at least two of the most powerful firstline anti tb medications drugs, isoniazid and rifampin. Mdrtb programs with success rates below 80% should consider redesigning their standardized and individualized regimens to include the new and repurposed tb drugs. Short mdrtb regimen an observational study in bangladesh showed much better rates of treatment success using regimens having a duration of 12 months or less who is advising countries to introduce short mdrtb treatment regimens only in projects that adhere to the following criteria. Standardised regimen for adults and children 8 years and older mdr tb treatment 49. These drugs are used to treat all persons with tb disease. Multidrugresistant tuberculosis mdr tb and extensively drugresistant tuberculosis xdr tb are posing a major public health threat as well as a big challenge for tb prevention and control in the european union and european economic area eueea. Treatment regimens for multidrugresistant tuberculosis.
1276 1514 915 1116 1684 306 763 1060 198 1434 357 1326 1593 351 1088 1057 447 390 220 1470 953 1514 1120 1041 1300 1549 1178 997 868 937 690 138 402 803 859 722 342 1281